Furthermore, early total expression levels of AKAP7 showed a modest ability to predict post-stroke BBB disruption, demonstrating 100% sensitivity (95% confidence interval = 63.1–100%) and 68.1% specificity (95% confidence interval = 43.5–87.0%) for the development of severe HARM (Fig. 2C). The gene discussed is AKAP7; the disease is stroke disorder.